All In MedTech

Device Trial Radar · NCT01853436

Impact of ADM in Reduction of Surgical Complexity of Breast Reconstructions With Implants (Nava)

Impact of Acellular Dermal Matrix in Reduction of Surgical Complexity of Breast Reconstructions With Implants

Last checked: Nov 19, 2026Latest source record: May 25, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

Terminated

Status

Terminated

Enrollment

36

Actual

Start

Mar 2013

Primary completion

Apr 2017

Study completion Jul 2017

Sponsor

Lead sponsor
LifeCellNot on our public-company list
Sponsor type
Industry
First posted
May 15, 2013

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to demonstrate that acellular dermal matrix, Strattice™ Reconstructive Tissue Matrix, can reduce the surgical complexity and post-operative pain of breast reconstructions with implants by avoiding one more surgical step in the operating room.

Conditions

  • Patients With Breast Cancer Requiring Mastectomy and Suitable for Reconstruction

Interventions

  • Strattice™ Reconstructive Tissue MatrixDevice

    Experimental arm: Device: Strattice Reconstructive Tissue Matrix Unilateral or bilateral mastectomy. Immediate breast reconstruction with sub-pectoralis muscle placement of a breast implant with ADM, single stage reconstruction technique. Control arm: Device: no device. Immediate breast tissue expander/implant based reconstruction with a two-stage reconstruction technique.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of surgeries where a differentiation will be made between major and minor depending upon the requirement to enter the breast pocket under general anesthesia.Time frame: At month 36 post-implant placement

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Fondazione IRCCS Instituto Nazionale dei Tumori

    Milan, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.